Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Blackfly Investments, LLC dba Molecular? Testing Labs
WARNING LETTER
•Blackfly Investments, LLC dba Molecular? Testing Labs•October 11, 2024

Blackfly Investments, LLC dba Molecular? Testing Labs – FDA Warning Letter, Oct 11, 2024

Record Details

On October 11, 2024, the FDA issued a Warning Letter to Blackfly Investments, LLC dba Molecular Testing Labs (MTL) for offering an HIV serological diagnostic dried blood spot (DBS) card self-collection kit without marketing authorization. The FDA determined the kit is a device under section 201(h)(1) of the FD&C Act.

The HIV DBS card self-collection kit is deemed adulterated under section 501(f)(1)(B) of the FD&C Act because it lacks an approved premarket approval application (PMA) or an approved investigational device exemption (IDE). It is also misbranded under section 502(o) of the FD&C Act due to the absence of a required 510(k) notification.

Despite prior communications and FDA recommendations to submit a De Novo request for marketing authorization, MTL has not done so. The FDA has not authorized the kit for any use, including HIV serological diagnostic testing. MTL's website continues to market the device, and the firm's January 18, 2024, response did not indicate discontinuation of the kit.

The FDA emphasizes the critical need to evaluate the kit's safety and effectiveness, including reliable sample collection and transport conditions. The FDA requests MTL cease activities resulting in misbranding or adulteration of the kit and provide a written response within fifteen working days detailing

Company
Blackfly Investments, LLC dba Molecular? Testing Labs
Inspection date
October 11, 2024
Product type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Melissa J. Mendoza (Director)
View Company Profile

ID · d285b1ff-41e6-4590-a643-0406498ede84

Violation Codes10
21 U.S.C. 321(h)(1)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)FD&C Act 201(h)(1)FD&C Act 501(f)(1)(B)FD&C Act 515(a)FD&C Act 520(g)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Blackfly Investments, LLC dba Molecular? Testing Labs
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.